{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:53:38Z","timestamp":1792659218313,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T00:00:00Z","timestamp":1302566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s11064-011-0469-3","type":"journal-article","created":{"date-parts":[[2011,4,21]],"date-time":"2011-04-21T14:48:48Z","timestamp":1303397328000},"page":"1435-1443","source":"Crossref","is-referenced-by-count":151,"title":["Protective Effect of Lycopene on Oxidative Stress and Cognitive Decline in Rotenone Induced Model of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"36","author":[{"given":"Harpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaveta","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Sandhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,12]]},"reference":[{"key":"469_CR1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","volume":"193","author":"A Hald","year":"2005","unstructured":"Hald A, Lotharius J (2005) Oxidative stress and inflammation in Parkinson\u2019s disease: is there a causal link? Exp Neurol 193:279\u2013290","journal-title":"Exp Neurol"},{"key":"469_CR2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/01.wnl.0000252807.38124.a3","volume":"68","author":"D Hirtz","year":"2007","unstructured":"Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R (2007) How common are the \u201ccommon\u201d neurologic disorders? Neurology 68:326\u2013337","journal-title":"Neurology"},{"key":"469_CR3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J (2008) Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368\u2013376","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"469_CR4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbrc.2010.07.033","volume":"399","author":"MC Maj","year":"2010","unstructured":"Maj MC, Tkachyova I, Patel P, Addis JB, Mackay N, Levandovskiy V, Lee J, Lang AE, Cameron JM, Robinson BH (2010) Oxidative stress alters the regulatory control of p66Shc and Akt in PINK1 deficient cells. Biochem Biophys Res Commun 399:331\u2013335","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl 3","key":"469_CR5","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1002\/ana.10488","volume":"53","author":"F Stocchi","year":"2003","unstructured":"Stocchi F, Olanow CW (2003) Neuroprotection in Parkinson\u2019s disease: clinical trials. Ann Neurol 53(Suppl 3):S87\u201397 discussion S97-89","journal-title":"Ann Neurol"},{"key":"469_CR6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/35072550","volume":"2","author":"MF Beal","year":"2001","unstructured":"Beal MF (2001) Experimental models of Parkinson\u2019s disease. Nat Rev Neurosci 2:325\u2013334","journal-title":"Nat Rev Neurosci"},{"key":"469_CR7","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909","journal-title":"Neuron"},{"key":"469_CR8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","volume":"136","author":"M Alam","year":"2002","unstructured":"Alam M, Schmidt WJ (2002) Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res 136:317\u2013324","journal-title":"Behav Brain Res"},{"key":"469_CR9","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 3:1301\u20131306","journal-title":"Nat Neurosci"},{"key":"469_CR10","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","volume":"23","author":"TB Sherer","year":"2003","unstructured":"Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT (2003) Mechanism of toxicity in rotenone models of Parkinson\u2019s disease. J Neurosci 23:10756\u201310764","journal-title":"J Neurosci"},{"key":"469_CR11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","volume":"28","author":"L Chen","year":"2008","unstructured":"Chen L, Ding Y, Cagniard B, Van Laar AD, Mortimer A, Chi W, Hastings TG, Kang UJ, Zhuang X (2008) Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J Neurosci 28:425\u2013433","journal-title":"J Neurosci"},{"key":"469_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12263-009-0143-4","volume":"4","author":"O Weinreb","year":"2009","unstructured":"Weinreb O, Amit T, Mandel S, Youdim MB (2009) Neuroprotective molecular mechanisms of (\u2212)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr 4:283\u2013296","journal-title":"Genes Nutr"},{"key":"469_CR13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2202-11-57","volume":"11","author":"MS Wang","year":"2010","unstructured":"Wang MS, Boddapati S, Emadi S, Sierks MR (2010) Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson\u2019s disease cell model. BMC Neurosci 11:57","journal-title":"BMC Neurosci"},{"key":"469_CR14","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1021\/jf8007212","volume":"56","author":"KT Lu","year":"2008","unstructured":"Lu KT, Ko MC, Chen BY, Huang JC, Hsieh CW, Lee MC, Chiou RY, Wung BS, Peng CH, Yang YL (2008) Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem 56:6910\u20136913","journal-title":"J Agric Food Chem"},{"key":"469_CR15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/JAD-2008-15314","volume":"15","author":"CD Kamat","year":"2008","unstructured":"Kamat CD, Gadal S, Mhatre M, Williamson KS, Pye QN, Hensley K (2008) Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J Alzheimers Dis 15:473\u2013493","journal-title":"J Alzheimers Dis"},{"key":"469_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/1011-1344(91)80266-K","volume":"11","author":"PF Conn","year":"1991","unstructured":"Conn PF, Schalch W, Truscott TG (1991) The singlet oxygen and carotenoid interaction. J Photochem Photobiol B 11:41\u201347","journal-title":"J Photochem Photobiol B"},{"key":"469_CR17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(96)00323-7","volume":"384","author":"NJ Miller","year":"1996","unstructured":"Miller NJ, Sampson J, Candeias LP, Bramley PM, Rice-Evans CA (1996) Antioxidant activities of carotenes and xanthophylls. FEBS Lett 384:240\u2013242","journal-title":"FEBS Lett"},{"key":"469_CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0014-5793(97)01355-0","volume":"418","author":"A Mortensen","year":"1997","unstructured":"Mortensen A, Skibsted LH, Sampson J, Rice-Evans C, Everett SA (1997) Comparative mechanisms and rates of free radical scavenging by carotenoid antioxidants. FEBS Lett 418:91\u201397","journal-title":"FEBS Lett"},{"key":"469_CR19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.taap.2006.03.006","volume":"215","author":"K Muzandu","year":"2006","unstructured":"Muzandu K, Ishizuka M, Sakamoto KQ, Shaban Z, El Bohi K, Kazusaka A, Fujita S (2006) Effect of lycopene and beta-carotene on peroxynitrite-mediated cellular modifications. Toxicol Appl Pharmacol 215:330\u2013340","journal-title":"Toxicol Appl Pharmacol"},{"key":"469_CR20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bbagen.2006.11.008","volume":"1770","author":"M Srinivasan","year":"2007","unstructured":"Srinivasan M, Sudheer AR, Pillai KR, Kumar PR, Sudhakaran PR, Menon VP (2007) Lycopene as a natural protector against gamma-radiation induced DNA damage, lipid peroxidation and antioxidant status in primary culture of isolated rat hepatocytes in vitro. Biochim Biophys Acta 1770:659\u2013665","journal-title":"Biochim Biophys Acta"},{"key":"469_CR21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00008469-199908000-00009","volume":"8","author":"A Sengupta","year":"1999","unstructured":"Sengupta A, Das S (1999) The anti-carcinogenic role of lycopene, abundantly present in tomato. Eur J Cancer Prev 8:325\u2013330","journal-title":"Eur J Cancer Prev"},{"key":"469_CR22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/07315724.1997.10718661","volume":"16","author":"H Gerster","year":"1997","unstructured":"Gerster H (1997) The potential role of lycopene for human health. J Am Coll Nutr 16:109\u2013126","journal-title":"J Am Coll Nutr"},{"key":"469_CR23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/14786410903417378","volume":"24","author":"SK Shukla","year":"2010","unstructured":"Shukla SK, Gupta S, Ojha SK, Sharma SB (2010) Cardiovascular friendly natural products: a promising approach in the management of CVD. Nat Prod Res 24:873\u2013898","journal-title":"Nat Prod Res"},{"key":"469_CR24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/ajcn\/79.1.47","volume":"79","author":"HD Sesso","year":"2004","unstructured":"Sesso HD, Buring JE, Norkus EP, Gaziano JM (2004) Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. Am J Clin Nutr 79:47\u201353","journal-title":"Am J Clin Nutr"},{"key":"469_CR25","first-page":"201","volume":"39","author":"Y Wei","year":"2010","unstructured":"Wei Y, Shen X, Shen H, Mai J, Wu M, Yao G (2010) Effects of lycopene on cerebral ischemia-reperfusion injury in rats. Wei Sheng Yan Jiu 39:201\u2013204","journal-title":"Wei Sheng Yan Jiu"},{"key":"469_CR26","first-page":"351","volume":"18","author":"G Hsiao","year":"2004","unstructured":"Hsiao G, Fong TH, Tzu NH, Lin KH, Chou DS, Sheu JR (2004) A potent antioxidant, lycopene, affords neuroprotection against microglia activation and focal cerebral ischemia in rats. In Vivo 18:351\u2013356","journal-title":"In Vivo"},{"key":"469_CR27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.neuint.2010.07.005","volume":"57","author":"R Sandhir","year":"2010","unstructured":"Sandhir R, Mehrotra A, Kamboj SS (2010) Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system. Neurochem Int 57:579\u2013587","journal-title":"Neurochem Int"},{"key":"469_CR28","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.lfs.2009.10.001","volume":"85","author":"P Kumar","year":"2009","unstructured":"Kumar P, Kalonia H, Kumar A (2009) Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity. Life Sci 85:711\u2013718","journal-title":"Life Sci"},{"key":"469_CR29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358","journal-title":"Anal Biochem"},{"key":"469_CR30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-9861(78)90479-4","volume":"186","author":"Y Kono","year":"1978","unstructured":"Kono Y (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186:189\u2013195","journal-title":"Arch Biochem Biophys"},{"key":"469_CR31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70\u201377","journal-title":"Arch Biochem Biophys"},{"key":"469_CR32","first-page":"52","volume-title":"Methods of enzymatic analysis","author":"M Whittaker","year":"1984","unstructured":"Whittaker M (1984) Cholinesterases. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York, pp 52\u201374"},{"key":"469_CR33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00004647-199901000-00004","volume":"19","author":"MA Perez-Pinzon","year":"1999","unstructured":"Perez-Pinzon MA, Xu GP, Born J, Lorenzo J, Busto R, Rosenthal M, Sick TJ (1999) Cytochrome C is released from mitochondria into the cytosol after cerebral anoxia or ischemia. J Cereb Blood Flow Metab 19:39\u201343","journal-title":"J Cereb Blood Flow Metab"},{"key":"469_CR34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0014-2999(91)90125-A","volume":"194","author":"J Itoh","year":"1991","unstructured":"Itoh J, Nabeshima T, Kameyama T (1991) Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. Eur J Pharmacol 194:71\u201376","journal-title":"Eur J Pharmacol"},{"key":"469_CR35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneumeth.2006.07.006","volume":"159","author":"HN Allbutt","year":"2007","unstructured":"Allbutt HN, Henderson JM (2007) Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson\u2019s disease. J Neurosci Methods 159:195\u2013202","journal-title":"J Neurosci Methods"},{"key":"469_CR36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0005-2728(98)00114-5","volume":"1366","author":"MF Beal","year":"1998","unstructured":"Beal MF (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1366:211\u2013223","journal-title":"Biochim Biophys Acta"},{"key":"469_CR37","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1046\/j.1471-4159.1995.65052146.x","volume":"65","author":"K Hensley","year":"1995","unstructured":"Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM et al (1995) Brain regional correspondence between Alzheimer\u2019s disease histopathology and biomarkers of protein oxidation. J Neurochem 65:2146\u20132156","journal-title":"J Neurochem"},{"key":"469_CR38","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/0929867013372995","volume":"8","author":"JD Adams Jr","year":"2001","unstructured":"Adams JD Jr, Chang ML, Klaidman L (2001) Parkinson\u2019s disease\u2014redox mechanisms. Curr Med Chem 8:809\u2013814","journal-title":"Curr Med Chem"},{"key":"469_CR39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10863-009-9250-6","volume":"41","author":"A Navarro","year":"2009","unstructured":"Navarro A, Boveris A (2009) Brain mitochondrial dysfunction and oxidative damage in Parkinson\u2019s disease. J Bioenerg Biomembr 41:517\u2013521","journal-title":"J Bioenerg Biomembr"},{"key":"469_CR40","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002","volume":"22","author":"TB Sherer","year":"2002","unstructured":"Sherer TB, Betarbet R, Stout AK, Lund S, Baptista M, Panov AV, Cookson MR, Greenamyre JT (2002) An in vitro model of Parkinson\u2019s disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J Neurosci 22:7006\u20137015","journal-title":"J Neurosci"},{"issue":"Suppl 2","key":"469_CR41","doi-asserted-by":"crossref","first-page":"ll1","DOI":"10.1007\/s00415-002-1201-7","volume":"249","author":"E Koutsilieri","year":"2002","unstructured":"Koutsilieri E, Scheller C, Grunblatt E, Nara K, Li J, Riederer P (2002) Free radicals in Parkinson\u2019s disease. J Neurol 249(Suppl 2):ll1\u2013ll5","journal-title":"J Neurol"},{"key":"469_CR42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0891-5849(91)90009-R","volume":"10","author":"JD Adams Jr","year":"1991","unstructured":"Adams JD Jr, Odunze IN (1991) Oxygen free radicals and Parkinson\u2019s disease. Free Radic Biol Med 10:161\u2013169","journal-title":"Free Radic Biol Med"},{"key":"469_CR43","first-page":"19","volume":"53","author":"C Singh","year":"2007","unstructured":"Singh C, Ahmad I, Kumar A (2007) Pesticides and metals induced Parkinson\u2019s disease: involvement of free radicals and oxidative stress. Cell Mol Biol (Noisy-le-grand) 53:19\u201328","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"469_CR44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.abb.2004.04.023","volume":"430","author":"K Wertz","year":"2004","unstructured":"Wertz K, Siler U, Goralczyk R (2004) Lycopene: modes of action to promote prostate health. Arch Biochem Biophys 430:127\u2013134","journal-title":"Arch Biochem Biophys"},{"key":"469_CR45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/abbi.2000.2035","volume":"383","author":"HR Matos","year":"2000","unstructured":"Matos HR, Di Mascio P, Medeiros MH (2000) Protective effect of lycopene on lipid peroxidation and oxidative DNA damage in cell culture. Arch Biochem Biophys 383:56\u201359","journal-title":"Arch Biochem Biophys"},{"key":"469_CR46","doi-asserted-by":"crossref","first-page":"51783","DOI":"10.1074\/jbc.M407336200","volume":"279","author":"GR Kweon","year":"2004","unstructured":"Kweon GR, Marks JD, Krencik R, Leung EH, Schumacker PT, Hyland K, Kang UJ (2004) Distinct mechanisms of neurodegeneration induced by chronic complex I inhibition in dopaminergic and non-dopaminergic cells. J Biol Chem 279:51783\u201351792","journal-title":"J Biol Chem"},{"key":"469_CR47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0005-2728(98)00109-1","volume":"1366","author":"J Cai","year":"1998","unstructured":"Cai J, Yang J, Jones DP (1998) Mitochondrial control of apoptosis: the role of cytochrome c. Biochim Biophys Acta 1366:139\u2013149","journal-title":"Biochim Biophys Acta"},{"key":"469_CR48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10863-009-9249-z","volume":"41","author":"M Marella","year":"2009","unstructured":"Marella M, Seo BB, Yagi T, Matsuno-Yagi A (2009) Parkinson\u2019s disease and mitochondrial complex I: a perspective on the Ndi1 therapy. J Bioenerg Biomembr 41:493\u2013497","journal-title":"J Bioenerg Biomembr"},{"key":"469_CR49","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1073\/pnas.88.5.1913","volume":"88","author":"A Jain","year":"1991","unstructured":"Jain A, Martensson J, Stole E, Auld PA, Meister A (1991) Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci USA 88:1913\u20131917","journal-title":"Proc Natl Acad Sci USA"},{"key":"469_CR50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF01291884","volume":"104","author":"RK Pearce","year":"1997","unstructured":"Pearce RK, Owen A, Daniel S, Jenner P, Marsden CD (1997) Alterations in the distribution of glutathione in the substantia nigra in Parkinson\u2019s disease. J Neural Transm 104:661\u2013677","journal-title":"J Neural Transm"},{"key":"469_CR51","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson\u2019s disease. J Neurochem 52:381\u2013389","journal-title":"J Neurochem"},{"key":"469_CR52","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","volume":"36","author":"J Sian","year":"1994","unstructured":"Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD (1994) Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36:348\u2013355","journal-title":"Ann Neurol"},{"key":"469_CR53","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1046\/j.1471-4159.1997.69031326.x","volume":"69","author":"ZI Alam","year":"1997","unstructured":"Alam ZI, Daniel SE, Lees AJ, Marsden DC, Jenner P, Halliwell B (1997) A generalised increase in protein carbonyls in the brain in Parkinson\u2019s but not incidental Lewy body disease. J Neurochem 69:1326\u20131329","journal-title":"J Neurochem"},{"key":"469_CR54","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1074\/jbc.M310341200","volume":"279","author":"AP Kudin","year":"2004","unstructured":"Kudin AP, Bimpong-Buta NY, Vielhaber S, Elger CE, Kunz WS (2004) Characterization of superoxide-producing sites in isolated brain mitochondria. J Biol Chem 279:4127\u20134135","journal-title":"J Biol Chem"},{"key":"469_CR55","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12012-010-9075-x","volume":"10","author":"H Wei","year":"2010","unstructured":"Wei H, Meng Z (2010) Epigallocatechin-3-gallate protects Na\u00a0+\u00a0channels in rat ventricular myocytes against sulfite. Cardiovasc Toxicol 10:166\u2013173","journal-title":"Cardiovasc Toxicol"},{"key":"469_CR56","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nutres.2009.12.002","volume":"30","author":"AA Alshatwi","year":"2010","unstructured":"Alshatwi AA, Al Obaaid MA, Al Sedairy SA, Al-Assaf AH, Zhang JJ, Lei KY (2010) Tomato powder is more protective than lycopene supplement against lipid peroxidation in rats. Nutr Res 30:66\u201373","journal-title":"Nutr Res"},{"key":"469_CR57","first-page":"415","volume":"48","author":"KS Bose","year":"2007","unstructured":"Bose KS, Agrawal BK (2007) Effect of lycopene from cooked tomatoes on serum antioxidant enzymes, lipid peroxidation rate and lipid profile in coronary heart disease. Singapore Med J 48:415\u2013420","journal-title":"Singapore Med J"},{"key":"469_CR58","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1099320","volume":"305","author":"DR Green","year":"2004","unstructured":"Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305:626\u2013629","journal-title":"Science"},{"key":"469_CR59","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1242\/jcs.114.15.2855","volume":"114","author":"W Gao","year":"2001","unstructured":"Gao W, Pu Y, Luo KQ, Chang DC (2001) Temporal relationship between cytochrome c release and mitochondrial swelling during UV-induced apoptosis in living HeLa cells. J Cell Sci 114:2855\u20132862","journal-title":"J Cell Sci"},{"key":"469_CR60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jnnp.48.5.413","volume":"48","author":"EK Perry","year":"1985","unstructured":"Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbairn A, Tomlinson BE, Perry RH (1985) Cholinergic correlates of cognitive impairment in Parkinson\u2019s disease: comparisons with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 48:413\u2013421","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"469_CR61","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0168-0102(02)00201-8","volume":"45","author":"JB Melo","year":"2003","unstructured":"Melo JB, Agostinho P, Oliveira CR (2003) Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neurosci Res 45:117\u2013127","journal-title":"Neurosci Res"},{"key":"469_CR62","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0278-5846(02)00316-0","volume":"27","author":"R Pillay","year":"2003","unstructured":"Pillay R, Maharaj DS, Daniel S, Daya S (2003) Acetylcholine reduces cyanide-induced superoxide anion generation and lipid peroxidation in rat brain homogenates. Prog Neuropsychopharmacol Biol Psychiatry 27:61\u201364","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"469_CR63","doi-asserted-by":"crossref","unstructured":"van Laar T, De Deyn PP, Aarsland D, Barone P, Galvin JE (2010) Effects of cholinesterase inhibitors in Parkinson\u2019s disease dementia: a review of clinical data. CNS Neurosci Ther [Epub ahead of print]","DOI":"10.1111\/j.1755-5949.2010.00166.x"},{"key":"469_CR64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1185\/030079902125001452","volume":"19","author":"C Gabelli","year":"2003","unstructured":"Gabelli C (2003) Rivastigmine: an update on therapeutic efficacy in Alzheimer\u2019s disease and other conditions. Curr Med Res Opin 19:69\u201382","journal-title":"Curr Med Res Opin"},{"key":"469_CR65","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT (2009) A highly reproducible rotenone model of Parkinson\u2019s disease. Neurobiol Dis 34:279\u2013290","journal-title":"Neurobiol Dis"},{"key":"469_CR66","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/13546800701202316","volume":"12","author":"P McNamara","year":"2007","unstructured":"McNamara P, Durso R, Harris E (2007) \u201cMachiavellianism\u201d and frontal dysfunction: evidence from Parkinson\u2019s disease. Cogn Neuropsychiatry 12:285\u2013300","journal-title":"Cogn Neuropsychiatry"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-011-0469-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-011-0469-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-011-0469-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:18:21Z","timestamp":1637540301000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-011-0469-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,12]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1007\/s11064-011-0469-3","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,12]]}}}